Improved renal recovery in patients with atypical hemolytic uremic syndrome following rapid initiation of eculizumab treatment

BACKGROUND: Eculizumab is approved for atypical hemolytic uremic syndrome (aHUS). Guidelines discuss the importance of prompt treatment. We report a post hoc analysis investigating the effect of baseline factors, including patient characteristics and time from the latest aHUS manifestation to eculiz...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Nephrol
Asıl Yazarlar: Walle, Johan Vande, Delmas, Yahsou, Ardissino, Gianluigi, Wang, Jimmy, Kincaid, John F., Haller, Herman
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer International Publishing 2016
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5316393/
https://ncbi.nlm.nih.gov/pubmed/26995002
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40620-016-0288-3
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller